We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
QDENGA Takeda Pharmaceuticals Australia Pty Ltd
Product name
QDENGA
Accepted date
Apr-2025
Active ingredients
dengue virus serotype 1, dengue virus serotype 2, dengue virus serotype 3, dengue virus serotype 4
Proposed indication
QDENGA is a vaccine for the prevention of dengue fever caused by any type of dengue virus in individuals aged 4 years and older.
Application type
A (new medicine)
Publication date
Apr-2025